GlassScriptPhysician profile
Timothy Shelburne Smith
NPI 1487729554
$5,825.12
in general payments reported to CMS, 2019-2025
9 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.52 · 2020: $140 · 2021: $615 · 2022: $3,138 · 2023: $1,531 · 2024: $96.66 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,380 · Food and Beverage: $345 · Gift: $87.20 · Entertainment: $21.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,380.00 |
| Food and Beverage | $345.14 |
| Gift | $87.20 |
| Entertainment | $21.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $3,000.00 | 2022 | |
| Dentsply Sirona INC | $1,997.33 | 2019-2025 | Astra Tech Implant System, Primescan Connect |
| Straumann USA LLC | $375.26 | 2019-2024 | |
| Geistlich Pharma, North America, INC. | $134.34 | 2022-2025 | Biomaterials, Geistlich Bio-Gide |
| Implant Direct Sybron International LLC | $132.97 | 2021-2022 | |
| Acumed LLC | $95.24 | 2025 | Osteomed |
| Nobel Biocare USA | $42.99 | 2021 | |
| Axogen | $26.99 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Patterson Companies, INC. | $20.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.